The Use of Citicoline in Ophthalmology: An Educational Article

Aamir Al-Mosawi
Additional contact information
Aamir Al-Mosawi: Advisor Doctor and Expert Trainer, The National Center of Training and Development, Iraqi Ministry of Health, Baghdad, Iraq

Journal of Innovations in Medical Research, 2023, vol. 2, issue 4, 11-13

Abstract: Objective: Citicoline is a safe form of the choline has been increasingly grouped with the water soluble B vitamins. It has been increasingly used with noticeable benefits in the treatment of several pediatric and neuro-psychiatric disorders including, cerebral palsy, cognitive impairment, autism disorders, Rett syndrome, and kernicterus. The aim of this paper is to provide an overview of citicoline research progress relevant to the field of ophthalmology. Conclusion: Citicoline is a safe agent that has the potential to have promising therapeutic applications in a variety of ophthalmological disorders including amblyopia, glaucoma, non-arteritic ischemic optic neuropathy, and diabetic retinopathy.

Keywords: Citicoline; ophthalmology; educational article (search for similar items in EconPapers)
Date: 2023
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.paradigmpress.org/jimr/article/view/564/481 (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:bdz:joimer:v:2:y:2023:i:4:p:11-13

DOI: 10.56397/JIMR/2023.04.02

Access Statistics for this article

More articles in Journal of Innovations in Medical Research from Paradigm Academic Press
Bibliographic data for series maintained by Editorial Office ().